Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease
- 30 April 2009
- journal article
- review article
- Published by Elsevier BV in Cytokine & Growth Factor Reviews
- Vol. 20 (2), 185-191
- https://doi.org/10.1016/j.cytogfr.2009.02.002
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Many cytokines are very useful therapeutic targets in diseaseJCI Insight, 2008
- A Fundamental Role for Interleukin-21 in the Generation of T Follicular Helper CellsImmunity, 2008
- The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancerCurrent Opinion in Immunology, 2008
- Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responsesTrends in Immunology, 2008
- Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac diseaseGut, 2008
- New players in the cytokine orchestra of inflammatory bowel diseaseInflammatory Bowel Diseases, 2007
- IL-21 Is Highly Produced in Helicobacter pylori-Infected Gastric Mucosa and Promotes Gelatinases SynthesisPublished by The American Association of Immunologists ,2007
- IL-21 Is Produced by NKT Cells and Modulates NKT Cell Activation and Cytokine ProductionPublished by The American Association of Immunologists ,2007
- Interleukin-21 enhances T-helper cell type I signaling and interferon-γ production in Crohn’s diseaseGastroenterology, 2005
- Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte functionNature, 2000